Clonazepam tablets & Hyaluronic Acid supplements | FDA Recall | Week of 18-Nov-2024 | GNHR

In the week of Nov 18, 2024, Endo Inc and MXBBB issued voluntary recalls for Clonazepam and Hyaluronic Acid due to package mislabeling and contaminations, respectively.

⏱️Chapters
0:16 - Clonazepam tablets
1:45 - Product Information
3:22 - Customer Action


4:02 - Hyaluronic Acid supplements
4:21 - Risks of Diclofenac
5:00 - Risks of Omeprazole
5:28 - Product Information
6:07 - Customer Action

#FDARecall #Recall #Safety #SafetyReports #Urgent #PublicHealth #Health #HealthReports #GNHR #ParPharmaceuticals #EndoInc #Clonazepam #Tablets #Mislabel #Umary #HyaluronicAcid #Diclofenac #Omeprazole #NSAID #PPI #Contaminations

📸Follow us on Instagram -   / gailehnhr  
🤳Follow us on TikTok -   / gailehnhr  

The content provided is for educational & informational purposes. Gail Ehn Health Reports (GNHR) is not affiliated, associated, authorized, endorsed by, or officially connected with the agencies and companies cited.